Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical data and approvals approach.

Harrow, Inc. is rapidly evolving into a dominant US ophthalmic pharma player, with a 30-fold revenue increase since 2015 and ...

I thought Pam was great,” Joan Armatrading says of her early lyric-writing partner, Pam Nestor. “She was totally different from me. Pam did all the things that I didn’t d ...

Ferrero scraps its traditional CEO role amid sweeping food and beverage leadership shakeups, introducing a dual executive model to strengthen core brands and accelerate growth across new platforms - ...

Welcome to the stage, NVIDIA Founder and CEO, Jensen Huang. Welcome to GTC. I just want to remind you, this is a tech conference. All these people are lining up so early in the morning, all of you in ...

Discover SonoPIN, a groundbreaking technique that uses ultrasound and microbubbles for targeted cancer treatment.

Authorities found 2.1 pounds of marijuana in Alabama basketball star Aden Holloway’s apartment when they arrested him Monday on a felony drug charge. That's according to court records released Tuesday ...

Bayer BAYRY announced that finerenone achieved the primary endpoint in the late-stage FIND-CKD study, marking a key milestone ...

In recent days, The Bank of Nova Scotia has raised new funding through multiple bond issues, including US$1.75 billion of fixed‑to‑floating covered bonds due March 13, 2029, and smaller callable ...

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 17, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custo ...

A bitter intraparty battle drew to a close Tuesday as Democratic primary voters went to the polls to decide who would be their choice to replace retiring U.S.